Log In

Term Description

This protocol provides information for drawing, processing, and storing blood for the herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) assay according to National Health and Nutrition Examination Survey (NHANES) methods. HSV-1 and HSV-2 are measured using the Solid-Phase Enzymatic Immunodot method.

Reference Information

TypeSourceReference
CitationConsensus measures for Phenotypes and ExposuresCenters for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
CitationConsensus measures for Phenotypes and ExposuresCenters for Disease Control and Prevention (CDC). (2007). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Emory University Division of Infectious Diseases, Immunology and Epidemiology Laboratory Procedures Manual for Herpes Simplex Virus Type 1 by Solid-Phase Enzymatic Immunodot. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
ArticleConsensus measures for Phenotypes and ExposuresLee, F. K., Pereira, L., & Griffin, C. (1986). A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. Journal of Virological Methods, 14, 111-118.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
62873-5PhenX - assay herpes simplex virus types 1 - 2 protocol 160501
Indent69862-1Exclusion criteria - assays PhenX
IndentIndent66177-7Do you have hemophilia?
IndentIndent66178-5Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Indent69863-9Process variables for assays PhenX
IndentIndent66504-2Exclusion Criteria
IndentIndent66180-1Was blood drawn?
IndentIndent66181-9Was full sample obtained?
IndentIndent8251-1Service comment
IndentIndent8251-1Service comment
IndentIndent66200-7Repeatability of the assay{ratio}
IndentIndent66201-5Coefficient of variation for the assay{CV}
Indent69864-7Manufacturer variables for assays PhenX
IndentIndent66208-0Make of the equipment used to perform...
IndentIndent74719-6Manufacturer of the equipment used

LOINC Names Get Info

Fully-Specified Name
PhenX - assay herpes simplex virus types 1 - 2 protocol 160501:-:Pt:^Patient:-:PhenX
Long Common Name
PhenX - assay herpes simplex virus types 1 - 2 protocol 160501
Short Name
Assay herpes simplex 1-2 proto

Part Model Get Info

  • Component
    PhenX - assay herpes simplex virus types 1 - 2 protocol 160501
    LP112430-6
    • Analyte
      PhenX - assay herpes simplex virus types 1 - 2 protocol 160501
      LP112430-6
      • Component Numerator
        PhenX - assay herpes simplex virus types 1 - 2 protocol 160501
        LP112430-6
        • Component Numerator Core
          PhenX - assay herpes simplex virus types 1 - 2 protocol 160501
          LP112430-6
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    ^Patient
    LP310005-6
    • System Core
      NULL
       
    • Super System
      Patient
      LP6985-8
  • Scale
    -
    LP7747-1
  • Method
    PhenX
    LP95333-8

Survey Question

PX160501

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.81 (MIN)
Change Reason
Release 2.81: Status: Changing PhenX Concept from Status = Trial to Active; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type
Panel

Member of these Panels

LOINCLong Common Name
62863-6PhenX domain - Infectious diseases and immunity

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)PhenX - προσδιορισμός ιού απλού έρπητα τύπου 1 - 2 πρωτόκολλο 160501:-:Pt:^Ασθενής:-:PhenX
Synonyms: - PANEL.PHENX PHENX PhenX - προσδιορισμός ιού απλού έρπητα τύπου 1 - 2 πρωτόκολλο 160501 Pt Ασθενής Ιός Ιός απλού έρπητα
es-MXSpanish (Mexico)PhenX - ensayo de virus del herpes simple tipos 1 - 2 protocolo 160501:-:Punto temporal:^ Paciente:-:PhenX
it-ITItalian (Italy)PhenX - esame per herpes simplex virus tipo 1 e 2, protocollo:-:Pt:^Paziente:-:PhenX
Synonyms: HSV Panel PhenX paziente PhenX Punto nel tempo (episodio)
ru-RURussian (Russian Federation)PhenX - анализ на herpes simplex вирус типы 1-2 протокол:-:ТчкВрм:^Пациент:-:PhenX
Synonyms: Точка во времени;Момент
zh-CNChinese (China)PhenX - 单纯疱疹病毒 1 - 2 型检测方案 160501:-:时间点:^患者:-:PhenX
Synonyms: Ⅰ Ⅱ Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 HSV;Herpes simplex virus;单疱病毒;单疱 I II PhenX - 单纯疱疹病毒 I - II 型检测方案 160501;Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 传染毒;传染毒素;滤过性病原体;病毒类;过滤性病原体 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.PhenX;组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 组 组合 组合医嘱 组合类 组套

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62873-5
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/62873-5